Companies /Healthcare

Johnson & Johnson

NYSE: JNJ Drug Manufacturers - General
$256.28
▲ $3.00 (+1.18%) today
Markets open · 10:08am ET

JNJ Coverage Page 66

4:01pm ET
Investing

The 4 Stocks That Pushed the Market Around

thinkstockMay 7, 2014: Markets opened higher on Wednesday but it turned into a miserable days for tech stocks and the Nasdaq Composite index. Lack of enthusiasm for momentum stocks pretty much sealed…

Paul Ausick
8:20am ET
Investing

RBC’s High-Yield Dividend Growth Stocks to Buy

In a new research report, RBC adds and deletes names from its Guided Portfolio: Dividend Growth offering. We screened them by sector, looking for the highest yield for income-oriented investors.

Jon C. Ogg
4:01pm ET
Investing

The 4 Stocks That Pulled the Markets Out of the Doldrums

thinkstockApril 15, 2014: Markets opened slightly higher on Tuesday with shares moving up before bouncing down after headlines related to confrontations in Ukraine. By afternoon markets had recovered somewhat to trade at…

Paul Ausick
11:02am ET
Technology

And Then There Were Three: ADP Loses Triple-A Rating

ThinkstockWhen Automatic Data Processing Inc. (NYSE: ADP) announced on Thursday that it would spin off its dealer services business, it didn’t take long for the credit ratings agencies to swing into action.…

Paul Ausick
8:10am ET
Investing

Highest Yielding UBS Dividend Ruler Stocks

ThinkstockThe more the market gets hit, the more people stare at their portfolios and wonder what would be the best additions. We frequently update the UBS Dividend Ruler stocks list, and now…

Jon C. Ogg
10:08am ET
Companies and Brands

Coca-Cola Tops Powerful Brands List

courtesy of The Coca-Cola CompanyOne of the world’s most recognized brand — The Coca-Cola Co. (NYSE: KO) — topped a new list of the world’s most powerful brands. The soft drink was followed…

Douglas A. McIntyre
10:55am ET
Health and Healthcare

Dendreon Finds New, Long Overdue Lifeblood

Shares of Dendreon moved higher Monday after the biotech company said it will start to market Provenge, its prostate-cancer drug, in Europe this year. Its fourth-quarter loss was smaller than expected as…

JNJ
cgblaine22